Teva was a disaster and at the time Mayne were a $2b market cap company ,atm sitting at 25% of that and to me and anyone can argue the fact but Mithra seem to have gotten the long straw again.Would take me a while to pull up all the figures but if you check all the deal announcements I think Mithra are pre post winners and Mayne are heavily dependant on a very successfull sales campaign which is far from a foregone conclusion,not denying E4’s outstanding qualities however at $200 per month for a women has to be questionably affordable for low to medium income earners.Happy to be found totally wrong as I still have a small holding but at only a minor % of what I once held as an excited holder.MYX was once my largest investment .
MYX CHART, page-125
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.26 |
Change
-0.020(0.47%) |
Mkt cap ! $362.4M | |||
| Open | High | Low | Value | Volume |
| $4.28 | $4.37 | $4.20 | $1.216M | 284.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12486 | $4.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.27 | 1060 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |